Profile data is unavailable for this security.
About the company
ProstaLund AB is a Sweden-based company that provides health care products and services. The Company develops and manufactures urological devices and treatments primarily for benign prostatic hyperplasia (BPH). The Company develops CoreTherm, a patented Thermotherapy treatment method for BPH, which takes approximately 6-15 minutes and offers long-term symptom relief. CoreTherm is used in hospitals and clinics in Sweden and worldwide.
- Revenue in SEK (TTM)17.57m
- Net income in SEK-21.64m
- Incorporated2007
- Employees6.00
- LocationProstaLund ABScheelevagen 19LUND 223 63SwedenSWE
- Phone+46 46120908
- Websitehttps://www.prostalund.se/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Invent Medic Sweden AB | 6.73m | -8.04m | 26.88m | 9.00 | -- | 5.51 | -- | 3.99 | -0.1939 | -0.1939 | 0.1613 | 0.0566 | 0.6084 | 2.31 | 4.34 | 841,046.30 | -72.67 | -97.56 | -133.97 | -121.06 | 77.43 | 77.16 | -119.45 | -490.98 | 0.3951 | -12.43 | 0.2703 | -- | 115.97 | 177.53 | 28.77 | -- | -22.61 | -- |
Miris Holding AB (publ) | 17.32m | -9.41m | 29.56m | 10.00 | -- | 3.81 | -- | 1.71 | -0.2092 | -0.2092 | 0.3641 | 0.0271 | 0.824 | 0.1117 | 7.25 | 1,732,100.00 | -44.74 | -59.61 | -95.35 | -111.08 | 97.83 | 86.68 | -54.30 | -103.61 | 0.7091 | -8.08 | 0.0903 | -- | -17.19 | 2.53 | -20.86 | -- | -- | -- |
Inhalation Sciences Sweden AB | 15.48m | -3.93m | 39.13m | 8.00 | -- | 3.48 | -- | 2.53 | -0.2796 | -0.2796 | 1.09 | 0.7409 | 0.8096 | 0.6328 | 4.37 | 1,935,000.00 | -20.53 | -27.93 | -29.23 | -43.82 | 86.29 | 71.13 | -25.36 | -48.02 | 2.81 | -6.49 | 0.0639 | -- | 43.55 | 26.33 | 60.87 | -- | -- | -- |
Scandinavian Real Heart AB | 0.00 | -75.02m | 46.12m | 12.00 | -- | 0.504 | -- | -- | -0.5182 | -0.5182 | 0.00 | 0.4425 | 0.00 | -- | -- | 0.00 | -73.46 | -24.27 | -87.03 | -26.81 | -- | 832.41 | -- | -6,070.11 | -- | -700.38 | 0.1023 | -- | -100.00 | -- | -385.97 | -- | -25.76 | -- |
Scandinavian ChemoTech AB | 4.61m | -16.98m | 47.29m | 6.00 | -- | 11.97 | -- | 10.25 | -1.04 | -1.04 | 0.2749 | 0.1821 | 0.2583 | 0.518 | 1.17 | 768,833.30 | -95.08 | -87.29 | -95.08 | -118.55 | 32.45 | 252.05 | -368.11 | -2,122.77 | -- | -14.56 | 0.00 | -- | 496.62 | 19.13 | 7.28 | -- | -- | -- |
ProstaLund AB | 17.57m | -21.64m | 49.22m | 6.00 | -- | 0.7072 | -- | 2.80 | -0.2752 | -0.2752 | 0.2226 | 0.5656 | 0.2627 | 0.3308 | 12.78 | -- | -32.35 | -29.14 | -39.54 | -35.01 | 72.73 | 75.26 | -123.16 | -68.94 | 0.7618 | -155.80 | 0.1065 | -- | 27.54 | 10.36 | -53.27 | -- | 20.35 | -- |
Bio Vitos Pharma AB | 1.11m | -14.84m | 50.83m | 1.00 | -- | 1.43 | -- | 45.84 | -0.1498 | -0.1498 | 0.006 | 0.0905 | 0.0457 | 0.092 | 3.02 | 1,108,910.00 | -61.08 | -31.11 | -62.90 | -32.92 | 90.59 | -- | -1,338.03 | -1,026.76 | 5.84 | -- | 0.00 | -- | 126.97 | -- | 13.64 | -- | -- | -- |
iZafe Group AB | 4.77m | -31.86m | 60.50m | 8.00 | -- | 2.94 | -- | 12.69 | -0.1332 | -0.1332 | 0.0202 | 0.0747 | 0.1111 | 2.67 | 3.41 | 681,285.70 | -74.23 | -52.17 | -85.90 | -69.40 | -167.81 | -198.20 | -668.02 | -487.50 | 0.6358 | -- | 0.1085 | -- | 149.93 | -24.79 | -36.76 | -- | -41.66 | -- |
Data as of Sep 20 2024. Currency figures normalised to ProstaLund AB's reporting currency: Swedish Krona SEK
Holder | Shares | % Held |
---|---|---|
FCG Fonder ABas of 30 Aug 2024 | 15.11k | 0.01% |
Data from 30 Aug 2024 - 30 Aug 2024Source: FactSet Research Systems Inc.